BYSI
BeyondSpring Inc.
Price Chart
No historical data available
Latest Quote
$0.67
+0.03 (+3.94%)
Current Price
| Previous Close | $0.64 |
| Open | $0.61 |
| Day High | $0.67 |
| Day Low | $0.61 |
| Volume | 113,572 |
Stock Information
| Shares Outstanding | 41.12M |
| Total Debt | $171K |
| Cash Equivalents | $6.53M |
| Net Income | $-7.29M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $27.36M |
| EPS (TTM) | $-0.19 |
| Exchange | NCM |
Recent Price History
No history data available. Data will be fetched automatically.
About BeyondSpring Inc.
BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform. The company's lead asset is Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia (CIN). It also develops Plinabulin in combination with Plinabulin+docetaxel vs. docetaxel alone for the treatment of NSCLC and epidermal growth factor receptor wild type. In addition, the company develops Plinabulin in combination with various immuno-oncology agents and chemotherapy and radiation; nivolumab, a PD-1 antibody that has completed phase 1 clinical trials for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer (ES-SCLC); in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers; and pembrolizumab, etoposide, and platinum to treat extensive-stage small cell lung cancer. Further, it engages in the development of three small-molecule immune agents in preclinical stages; and a drug discovery platform to develop therapeutic agents from internal research and development efforts and from collaboration. The company was founded in 2010 and is headquartered in Florham Park, New Jersey.
đ° Latest News
No news articles available at the moment. Check back later for updates on BYSI.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $1,351,000 |
| Operating Revenue | $0 | $0 | $0 | $1,351,000 |
| Expenses | ||||
| Total Expenses | $8,945,000 | $8,754,000 | $15,081,000 | $38,590,000 |
| Other Income Expense | $242,000 | $-74,000 | $836,000 | $944,000 |
| Other Non Operating Income Expenses | $77,000 | $22,000 | $964,000 | $1,373,000 |
| Net Non Operating Interest Income Expense | $78,000 | $59,000 | $322,000 | $178,000 |
| Operating Expense | $8,945,000 | $8,754,000 | $15,081,000 | $38,590,000 |
| General And Administrative Expense | $4,557,000 | $6,110,000 | $7,809,000 | $13,008,000 |
| Interest Expense | - | - | $0 | $17,000 |
| Interest Expense Non Operating | - | - | $0 | $17,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $4,496,000 | $-3,295,000 | $-13,093,000 | $-33,279,000 |
| Net Interest Income | $78,000 | $59,000 | $322,000 | $178,000 |
| Interest Income | $78,000 | $59,000 | $322,000 | $195,000 |
| Normalized Income | $4,365,650 | $-3,219,160 | $-12,991,880 | $-32,940,090 |
| Net Income From Continuing And Discontinued Operation | $-1,006,000 | $-11,123,000 | $-21,026,000 | $-33,279,000 |
| Total Operating Income As Reported | $-8,945,000 | $-8,754,000 | $-15,081,000 | $-37,239,000 |
| Net Income Common Stockholders | $-1,006,000 | $-11,123,000 | $-21,026,000 | $-33,279,000 |
| Net Income | $-1,006,000 | $-11,123,000 | $-21,026,000 | $-33,279,000 |
| Net Income Including Noncontrolling Interests | $-14,217,000 | $-16,693,000 | $-21,948,000 | $-36,280,000 |
| Net Income Discontinuous Operations | $-5,502,000 | $-7,828,000 | $-7,933,000 | - |
| Net Income Continuous Operations | $-8,715,000 | $-8,865,000 | $-14,015,000 | $-36,280,000 |
| Pretax Income | $-8,625,000 | $-8,769,000 | $-13,923,000 | $-36,117,000 |
| Interest Income Non Operating | $78,000 | $59,000 | $322,000 | $195,000 |
| Operating Income | $-8,945,000 | $-8,754,000 | $-15,081,000 | $-37,239,000 |
| Per Share | ||||
| Diluted EPS | $-0.02 | $-0.28 | $-0.54 | $-0.85 |
| Basic EPS | $-0.02 | $-0.28 | $-0.54 | $-0.85 |
| Other | ||||
| Tax Effect Of Unusual Items | $34,650 | $-20,160 | $-26,880 | $-90,090 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-9,023,000 | $-8,373,000 | $-14,651,000 | $-35,439,000 |
| Total Unusual Items | $165,000 | $-96,000 | $-128,000 | $-429,000 |
| Total Unusual Items Excluding Goodwill | $165,000 | $-96,000 | $-128,000 | $-429,000 |
| Reconciled Depreciation | $87,000 | $285,000 | $302,000 | $232,000 |
| EBITDA (Bullshit earnings) | $-8,858,000 | $-8,469,000 | $-14,779,000 | $-35,868,000 |
| EBIT | $-8,945,000 | $-8,754,000 | $-15,081,000 | $-36,100,000 |
| Diluted Average Shares | $40,406,347 | $39,733,191 | $38,996,463 | $39,093,246 |
| Basic Average Shares | $40,406,347 | $39,733,191 | $38,996,463 | $39,093,246 |
| Diluted NI Availto Com Stockholders | $-1,006,000 | $-11,123,000 | $-21,026,000 | $-33,279,000 |
| Minority Interests | $13,211,000 | $5,570,000 | $922,000 | $3,001,000 |
| Tax Provision | $90,000 | $96,000 | $92,000 | $163,000 |
| Gain On Sale Of Security | $165,000 | $-96,000 | $-128,000 | $-429,000 |
| Research And Development | $4,388,000 | $2,644,000 | $7,272,000 | $25,582,000 |
| Selling General And Administration | $4,557,000 | $6,110,000 | $7,809,000 | $13,008,000 |
| Other Gand A | $4,557,000 | $6,110,000 | $7,809,000 | $13,008,000 |
Fetched: 2026-08-30
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-32,161,000 | $-32,900,000 | $-26,805,000 | $-5,979,000 |
| Total Assets | $25,933,000 | $34,315,000 | $24,808,000 | $46,222,000 |
| Total Non Current Assets | $5,051,000 | $5,738,000 | $6,389,000 | $7,699,000 |
| Other Non Current Assets | $4,455,000 | $4,873,000 | $5,324,000 | $339,000 |
| Non Current Accounts Receivable | $125,000 | $113,000 | $18,000 | $8,000 |
| Current Assets | $20,882,000 | $28,577,000 | $18,419,000 | $38,523,000 |
| Other Current Assets | $71,000 | $68,000 | $168,000 | $763,000 |
| Assets Held For Sale Current | $8,023,000 | $25,347,000 | $2,622,000 | - |
| Prepaid Assets | $227,000 | $240,000 | $292,000 | $492,000 |
| Cash Cash Equivalents And Short Term Investments | $12,561,000 | $2,922,000 | $5,396,000 | $37,268,000 |
| Cash And Cash Equivalents | $7,786,000 | $2,922,000 | $5,396,000 | $34,396,000 |
| Restricted Cash | - | $0 | $9,941,000 | $0 |
| Debt | ||||
| Total Debt | $320,000 | $589,000 | $847,000 | $4,961,000 |
| Long Term Debt And Capital Lease Obligation | $0 | $307,000 | $589,000 | $3,995,000 |
| Current Debt And Capital Lease Obligation | $320,000 | $282,000 | $258,000 | $966,000 |
| Current Debt | - | - | - | - |
| Other Current Borrowings | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $49,923,000 | $48,600,000 | $48,269,000 | $49,229,000 |
| Total Non Current Liabilities Net Minority Interest | $36,347,000 | $37,590,000 | $40,311,000 | $41,877,000 |
| Liabilities Heldfor Sale Non Current | $3,766,000 | $6,197,000 | $7,847,000 | - |
| Tradeand Other Payables Non Current | $3,891,000 | $3,613,000 | $3,593,000 | $3,576,000 |
| Non Current Deferred Liabilities | $28,600,000 | $27,400,000 | $28,170,000 | $34,221,000 |
| Current Liabilities | $13,576,000 | $11,010,000 | $7,958,000 | $7,352,000 |
| Other Current Liabilities | $11,169,000 | $8,980,000 | $3,807,000 | $122,000 |
| Payables And Accrued Expenses | $1,549,000 | $1,136,000 | $2,926,000 | $3,583,000 |
| Payables | $611,000 | $296,000 | $579,000 | $1,113,000 |
| Total Tax Payable | $248,000 | $1,000 | $18,000 | $32,000 |
| Accounts Payable | $363,000 | $295,000 | $561,000 | $1,081,000 |
| Current Deferred Liabilities | - | - | $1,751,000 | $1,351,000 |
| Income Tax Payable | - | - | - | $16,000 |
| Other Non Current Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $-32,161,000 | $-32,900,000 | $-26,805,000 | $-5,979,000 |
| Total Equity Gross Minority Interest | $-23,990,000 | $-14,285,000 | $-23,461,000 | $-3,007,000 |
| Stockholders Equity | $-32,161,000 | $-32,900,000 | $-26,805,000 | $-5,979,000 |
| Gains Losses Not Affecting Retained Earnings | $602,000 | $1,336,000 | $894,000 | $436,000 |
| Retained Earnings | $-408,431,000 | $-407,425,000 | $-396,302,000 | $-375,276,000 |
| Other Equity Adjustments | - | - | - | $436,000 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $41,122,320 | $40,316,320 | $39,029,163 | $38,999,597 |
| Share Issued | $41,122,320 | $40,316,320 | $39,029,163 | $38,999,597 |
| Tangible Book Value | $-32,161,000 | $-32,900,000 | $-26,805,000 | $-5,979,000 |
| Invested Capital | $-32,161,000 | $-32,900,000 | $-26,805,000 | $-5,979,000 |
| Working Capital | $7,306,000 | $17,567,000 | $10,461,000 | $31,171,000 |
| Capital Lease Obligations | $320,000 | $589,000 | $847,000 | $4,961,000 |
| Total Capitalization | $-32,161,000 | $-32,900,000 | $-26,805,000 | $-5,979,000 |
| Minority Interest | $8,171,000 | $18,615,000 | $3,344,000 | $2,972,000 |
| Foreign Currency Translation Adjustments | $602,000 | $1,336,000 | $894,000 | $436,000 |
| Additional Paid In Capital | $375,664,000 | $373,185,000 | $368,599,000 | $368,857,000 |
| Capital Stock | $4,000 | $4,000 | $4,000 | $4,000 |
| Common Stock | $4,000 | $4,000 | $4,000 | $4,000 |
| Employee Benefits | $90,000 | $73,000 | $112,000 | $85,000 |
| Non Current Deferred Revenue | $28,600,000 | $27,400,000 | $28,170,000 | $34,221,000 |
| Long Term Capital Lease Obligation | $0 | $307,000 | $589,000 | $3,995,000 |
| Current Capital Lease Obligation | $320,000 | $282,000 | $258,000 | $966,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $538,000 | $612,000 | $967,000 | $1,330,000 |
| Current Accrued Expenses | $938,000 | $840,000 | $2,347,000 | $2,470,000 |
| Net PPE | $471,000 | $752,000 | $1,047,000 | $7,352,000 |
| Accumulated Depreciation | $-641,000 | $-554,000 | $-482,000 | $-551,000 |
| Gross PPE | $1,112,000 | $1,306,000 | $1,529,000 | $7,903,000 |
| Leases | $271,000 | $271,000 | $272,000 | $272,000 |
| Other Properties | $420,000 | $624,000 | $843,000 | $6,983,000 |
| Machinery Furniture Equipment | $421,000 | $411,000 | $414,000 | $648,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $4,775,000 | $0 | $193,000 | $2,872,000 |
| Current Deferred Revenue | - | - | $1,751,000 | $1,351,000 |
| Construction In Progress | - | - | - | $0 |
Fetched: 2026-08-30
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-19,819,000 | $-16,667,000 | $-16,574,000 | $-28,185,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-19,769,000 | $-16,443,000 | $-16,474,000 | $-28,151,000 |
| Cash Flow From Continuing Operating Activities | $-19,769,000 | $-16,443,000 | $-16,474,000 | $-28,151,000 |
| Operating Gains Losses | $-6,986,000 | - | $37,000 | $-1,071,000 |
| Investing Activities | ||||
| Capital Expenditure | $-50,000 | $-224,000 | $-100,000 | $-34,000 |
| Investing Cash Flow | $10,787,000 | $-12,012,000 | $-100,000 | $18,247,000 |
| Cash Flow From Continuing Investing Activities | $10,787,000 | $-12,012,000 | $-100,000 | $18,247,000 |
| Net Other Investing Changes | - | - | - | $-687,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $2,000,000 | $3,000,000 | $0 | $0 |
| Financing Cash Flow | $4,968,000 | $26,785,000 | $4,000 | $3,431,000 |
| Cash Flow From Continuing Financing Activities | $4,968,000 | $26,785,000 | $4,000 | $3,431,000 |
| Net Other Financing Charges | $2,682,000 | $19,874,000 | - | $5,000,000 |
| Net Common Stock Issuance | $2,000,000 | $3,000,000 | $0 | $0 |
| Common Stock Issuance | $2,000,000 | $3,000,000 | $0 | $0 |
| Other | ||||
| Issuance Of Debt | $286,000 | $3,911,000 | $0 | $0 |
| Interest Paid Supplemental Data | $0 | $0 | $0 | $17,000 |
| Income Tax Paid Supplemental Data | $2,000 | $7,000 | $36,000 | $367,000 |
| End Cash Position | $7,786,000 | $2,922,000 | $15,337,000 | $34,396,000 |
| Other Cash Adjustment Outside Changein Cash | $-4,352,000 | $-13,125,000 | $-2,413,000 | - |
| Beginning Cash Position | $16,047,000 | $17,750,000 | $34,396,000 | $41,625,000 |
| Effect Of Exchange Rate Changes | $105,000 | $-33,000 | $-76,000 | $-756,000 |
| Changes In Cash | $-4,014,000 | $-1,670,000 | $-16,570,000 | $-6,473,000 |
| Net Issuance Payments Of Debt | $286,000 | $3,911,000 | $0 | $-1,569,000 |
| Net Long Term Debt Issuance | $286,000 | $3,911,000 | $0 | $-1,569,000 |
| Long Term Debt Issuance | $286,000 | $3,911,000 | $0 | $0 |
| Net Investment Purchase And Sale | $3,483,000 | $-11,788,000 | $0 | $17,564,000 |
| Sale Of Investment | $18,432,000 | $1,000,000 | $1,300,000 | $49,761,000 |
| Purchase Of Investment | $-14,949,000 | $-12,788,000 | $-1,300,000 | $-32,197,000 |
| Net Business Purchase And Sale | $7,354,000 | $0 | - | - |
| Sale Of Business | $7,354,000 | $0 | - | - |
| Net PPE Purchase And Sale | $-50,000 | $-224,000 | $-100,000 | $683,000 |
| Purchase Of PPE | $-50,000 | $-224,000 | $-100,000 | $-34,000 |
| Change In Working Capital | $-122,000 | $-2,989,000 | $3,283,000 | $6,409,000 |
| Change In Other Working Capital | $-2,001,000 | $-1,001,000 | $249,000 | $-1,351,000 |
| Change In Other Current Liabilities | $-145,000 | $-804,000 | $-823,000 | $-3,194,000 |
| Change In Other Current Assets | $212,000 | $-181,000 | $2,641,000 | $11,583,000 |
| Change In Payables And Accrued Expense | $1,766,000 | $-994,000 | $437,000 | $-1,963,000 |
| Change In Accrued Expense | $1,842,000 | $-387,000 | $111,000 | $-1,388,000 |
| Change In Payable | $-76,000 | $-607,000 | $326,000 | $-575,000 |
| Change In Account Payable | $-76,000 | $-607,000 | $326,000 | $-575,000 |
| Change In Prepaid Assets | $46,000 | $-9,000 | $779,000 | $1,334,000 |
| Other Non Cash Items | $747,000 | $702,000 | $1,086,000 | $912,000 |
| Stock Based Compensation | $722,000 | $2,255,000 | $770,000 | $1,666,000 |
| Unrealized Gain Loss On Investment Securities | $0 | $-3,000 | $-4,000 | $-19,000 |
| Depreciation Amortization Depletion | $87,000 | $285,000 | $302,000 | $232,000 |
| Depreciation And Amortization | $87,000 | $285,000 | $302,000 | $232,000 |
| Depreciation | $87,000 | $285,000 | $302,000 | $232,000 |
| Gain Loss On Sale Of Business | $-6,986,000 | $0 | - | - |
| Net Income From Continuing Operations | $-14,217,000 | $-16,693,000 | $-21,948,000 | $-36,280,000 |
| Proceeds From Stock Option Exercised | - | $0 | $4,000 | $0 |
| Gain Loss On Sale Of PPE | - | $0 | $37,000 | $0 |
| Repayment Of Debt | - | - | $0 | $-1,569,000 |
| Long Term Debt Payments | - | - | $0 | $-1,569,000 |
| Sale Of PPE | - | - | $0 | $717,000 |
| Gain Loss On Investment Securities | - | - | - | $-1,071,000 |
| Change In Receivables | - | - | - | - |
Fetched: 2026-08-30